OLR1 and Stroke: Notably, our findings revealed additional intriguing insights: (1) there was a significant negative correlation between serum sLOX-1 levels and patients’ GCS scores, alongside a significant positive correlation with hematoma volumes; (2) serum sLOX-1 was identified as an independent predictor of poor prognosis at 3 months post-stroke; (3) there was a high predictive ability of serum sLOX-1 levels for poor prognosis in sICH; and (4) the predictive ability of serum sLOX-1 levels for poor prognosis were similar to those of GCS scores and hematoma volumes.